Clinical Trial Update: Comparative Bioavailability of Intranasal Epinephrine [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the comparative bioavailability of intranasal epinephrine for anaphylaxis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaphylaxis

Drugs mentioned

• intranasal epinephrine (epinephrine)

Snippet

Sponsor: Nasus Pharma | Conditions: Anaphylaxis, Anaphylactic Reaction | Phase 1, Phase 2 | Status: COMPLETED